Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Amortizatization of Intangibles (2019 - 2025)

Harmony Biosciences Holdings' Amortizatization of Intangibles history spans 7 years, with the latest figure at $281000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 98.73% year-over-year to $281000.0; the TTM value through Dec 2025 reached $1.5 million, down 93.62%, while the annual FY2025 figure was $1.5 million, 93.62% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $281000.0 at Harmony Biosciences Holdings, up from -$5.2 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $22.1 million in Q4 2024 and bottomed at -$16.6 million in Q4 2022.
  • The 5-year median for Amortizatization of Intangibles is $2.6 million (2021), against an average of $2.3 million.
  • The largest annual shift saw Amortizatization of Intangibles surged 1825.0% in 2022 before it tumbled 1040.36% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $9.0 million in 2021, then crashed by 285.0% to -$16.6 million in 2022, then grew by 8.47% to -$15.2 million in 2023, then soared by 245.53% to $22.1 million in 2024, then tumbled by 98.73% to $281000.0 in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Amortizatization of Intangibles are $281000.0 (Q4 2025), -$5.2 million (Q3 2025), and $6.0 million (Q2 2025).